246 related articles for article (PubMed ID: 17057755)
1. Positive inotropic effects of carbon monoxide-releasing molecules (CO-RMs) in the isolated perfused rat heart.
Musameh MD; Fuller BJ; Mann BE; Green CJ; Motterlini R
Br J Pharmacol; 2006 Dec; 149(8):1104-12. PubMed ID: 17057755
[TBL] [Abstract][Full Text] [Related]
2. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule.
Motterlini R; Sawle P; Hammad J; Bains S; Alberto R; Foresti R; Green CJ
FASEB J; 2005 Feb; 19(2):284-6. PubMed ID: 15556971
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of carbon monoxide-releasing molecules on post-ischemic myocardial recovery.
Varadi J; Lekli I; Juhasz B; Bacskay I; Szabo G; Gesztelyi R; Szendrei L; Varga E; Bak I; Foresti R; Motterlini R; Tosaki A
Life Sci; 2007 Apr; 80(17):1619-26. PubMed ID: 17321552
[TBL] [Abstract][Full Text] [Related]
5. Carbon monoxide rapidly impairs alveolar fluid clearance by inhibiting epithelial sodium channels.
Althaus M; Fronius M; Buchäckert Y; Vadász I; Clauss WG; Seeger W; Motterlini R; Morty RE
Am J Respir Cell Mol Biol; 2009 Dec; 41(6):639-50. PubMed ID: 19251942
[TBL] [Abstract][Full Text] [Related]
6. CO liberated from a carbon monoxide-releasing molecule exerts a positive inotropic effect in doxorubicin-induced cardiomyopathy.
Musameh MD; Green CJ; Mann BE; Motterlini R; Fuller BJ
J Cardiovasc Pharmacol; 2010 Feb; 55(2):168-75. PubMed ID: 19935076
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of platelet aggregation by carbon monoxide-releasing molecules (CO-RMs): comparison with NO donors.
Chlopicki S; Lomnicka M; Fedorowicz A; Grochal E; Kramkowski K; Mogielnicki A; Buczko W; Motterlini R
Naunyn Schmiedebergs Arch Pharmacol; 2012 Jun; 385(6):641-50. PubMed ID: 22362133
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.
Clark JE; Naughton P; Shurey S; Green CJ; Johnson TR; Mann BE; Foresti R; Motterlini R
Circ Res; 2003 Jul; 93(2):e2-8. PubMed ID: 12842916
[TBL] [Abstract][Full Text] [Related]
9. [Cardioprotection and mechanisms of exogenous carbon monoxide releaser CORM-2 against ischemia/reperfusion injury in isolated rat hearts].
Mei DS; Du YA; Wang Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 May; 36(3):291-7. PubMed ID: 17571314
[TBL] [Abstract][Full Text] [Related]
10. Renal vascular responses to CORM-A1 in the mouse.
Ryan MJ; Jernigan NL; Drummond HA; McLemore GR; Rimoldi JM; Poreddy SR; Gadepalli RS; Stec DE
Pharmacol Res; 2006 Jul; 54(1):24-9. PubMed ID: 16524742
[TBL] [Abstract][Full Text] [Related]
11. Improved myocardial function after cold storage with preservation solution supplemented with a carbon monoxide-releasing molecule (CORM-3).
Musameh MD; Green CJ; Mann BE; Fuller BJ; Motterlini R
J Heart Lung Transplant; 2007 Nov; 26(11):1192-8. PubMed ID: 18022087
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effect with carbon monoxide releasing molecule-2 (CORM-2) in isolated perfused rat heart: Role of coronary endothelium and underlying mechanism.
Soni H; Patel P; Rath AC; Jain M; Mehta AA
Vascul Pharmacol; 2010; 53(1-2):68-76. PubMed ID: 20399902
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic applications of carbon monoxide-releasing molecules.
Motterlini R; Mann BE; Foresti R
Expert Opin Investig Drugs; 2005 Nov; 14(11):1305-18. PubMed ID: 16255672
[TBL] [Abstract][Full Text] [Related]
14. Effects of carbon monoxide-releasing molecules on pulmonary vasoreactivity in isolated perfused lungs.
Pak O; Bakr AG; Gierhardt M; Albus J; Strielkov I; Kroschel F; Hoeres T; Hecker M; Ghofrani HA; Seeger W; Weissmann N; Sommer N
J Appl Physiol (1985); 2016 Jan; 120(2):271-81. PubMed ID: 26586910
[TBL] [Abstract][Full Text] [Related]
15. Vasorelaxing effects and inhibition of nitric oxide in macrophages by new iron-containing carbon monoxide-releasing molecules (CO-RMs).
Motterlini R; Sawle P; Hammad J; Mann BE; Johnson TR; Green CJ; Foresti R
Pharmacol Res; 2013 Feb; 68(1):108-17. PubMed ID: 23253427
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule.
Foresti R; Hammad J; Clark JE; Johnson TR; Mann BE; Friebe A; Green CJ; Motterlini R
Br J Pharmacol; 2004 Jun; 142(3):453-60. PubMed ID: 15148243
[TBL] [Abstract][Full Text] [Related]
17. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
18. Heme is required for carbon monoxide activation of mitochondrial BK
Rotko D; Bednarczyk P; Koprowski P; Kunz WS; Szewczyk A; Kulawiak B
Eur J Pharmacol; 2020 Aug; 881():173191. PubMed ID: 32422186
[TBL] [Abstract][Full Text] [Related]
19. Various inotropic effects of angiotensin II in post-ischaemic rat hearts depending on ischaemic time with possible involvement of protein kinase C.
Wang QD; Nygren E
Acta Physiol Scand; 2003 Jul; 178(3):189-96. PubMed ID: 12823176
[TBL] [Abstract][Full Text] [Related]
20. Positive inotropic, positive chronotropic and coronary vasodilatory effects of rat amylin: mechanisms of amylin-induced positive inotropy.
Kaygisiz Z; Ozden H; Erkasap N; Koken T; Gunduz T; Ikizler M; Kural T
Acta Physiol Hung; 2010 Dec; 97(4):362-74. PubMed ID: 21138812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
